• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Collaboration: A Good Thing!

  • Tue, 2/9/10 - 10:27am
  • 2398 reads
  • 2 comments

Vascular surgeons have developed clinical and technical skills that allow us to care for many of our patients on our own. In light of this, I think many of us have forgotten that there is a benefit to our patients to have more than one opinion regarding their most optimal care. As mentioned in my last blog, I recently moved to a new medical center. One of the biggest transitions in my professional life is a setting in which I work side by side in the Heart and Vascular Center with other specialists, including neurologists and cardiologists.

I have taken care of several patients in a short period of time when many people have been involved in making the best recommendation to the patients regarding their care. This includes carotid disease and lower extremity arterial occlusive disease. In addition, I have stood across the interventional table from two different cardiologists so that we could fix aneurysms together with fellows from both of our services. For you skeptics out there, this was not just to provide cutdowns for someone who can not surgically expose an artery. In fact, we did one of the aneurysms in a percutaneous fashion as per my suggestion. We all benefited from working together for these patients. So…stents and surgical incisions can live together in order to provide the best for our patients!

Ross Milner, MD, FACS
Chief, Division of Vascular Surgery and
Endovascular Therapy

____________________________________________________________________

Ross Milner, MD, FACS is associate professor of surgery at Loyola University Chicago Stritch School of Medicine. He was recruited to Loyola from Emory University School of Medicine in Atlanta, where he was associate professor of surgery.

Dr. Milner graduated Cum Laude from the University of Pennsylvania, where he also completed medical school. He was chief resident in surgery at the Hospital of the University of Pennsylvania. He completed fellowships at the University of Pennsylvania and University Medical Center in Utrecht in the Netherlands. Dr. Milner is currently Chief of the Division of Vascular Surgery and Endovascular Therapy at Loyola University Medical Center, Stritch School of Medicine in Chicago, Illinois.

image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


hmpjournalssays: February 17.2010 at 01:21 am

Posted by Anonymous on February 10, 2010 at 1:02 pm
Dr.Milner's comments epitomize how we should approach vascular disease. My personal training has included education from surgeons, interventional radiologists, vascular medicine specialists, and cardiologists. From each, I have been able to learn something new and approach disease states with a slightly different perspective. I am lucky to have been one of those cardiologists that he referred to with the percutaneous EVAR. In fact, I initially thought the patient was not the best candidate for EVAR- however, with his help and his colleagues, the result was outstanding. These patients are complex and the best care is delivered in a multidisciplinary fashion.

Reply to this comment »
Anonymoussays: February 10.2010 at 13:41 pm

Dr.Milner's comments epitomize how we should approach vascular disease. My personal training has included education from surgeons, interventional radiologists, vascular medicine specialists, and cardiologists. From each, I have been able to learn something new and approach disease states with a slightly different perspective. I am lucky to have been one of those cardiologists that he referred to with the percutaneous EVAR. In fact, I initially thought the patient was not the best candidate for EVAR- however, with his help and his colleagues, the result was outstanding. These patients are complex and the best care is delivered in a multidisciplinary fashion.

Reply to this comment »

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
    Fri, 02/10/12 - 11:12am
  • Stereotaxis Announces European Adoption Milestone and Health Canada Market Clearance for Vdrive System
    Fri, 02/10/12 - 11:08am
  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications